New cell therapy targets Hard-to-Treat kidney cancer
NCT ID NCT06245915
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 30 times
Summary
This study tests a new cell therapy called AB-2100 for people with advanced or metastatic clear-cell kidney cancer that has come back after other treatments. About 37 to 130 participants will receive the therapy to see if it is safe and shrinks tumors. The goal is to control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Dana Farber Cancer Institue
Boston, Massachusetts, 02215, United States
-
Huntsman Cancer Institute - Univ of Utah Health
Salt Lake City, Utah, 84112, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic Hospital
Phoenix, Arizona, 85054, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Perlmutter Cancer Center - NYU Langone Health
New York, New York, 10016, United States
-
University of Iowa and Holden Comprehensive Cancer Center
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.